First Tracks Biotherapeutics TRAX Growth Metrics (2025-2026)

NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

First Tracks Biotherapeutics Quarterly Growth Metrics

Periods 7 quarters
Latest Sep 2026

First Tracks Biotherapeutics growth metrics data for the quarter ended Sep 2026. These growth metrics cover 7 quarters of results from Mar 2025 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Growth Ratios
Share-based Compensation (QoQ)Stock Comp. (QoQ) -1.16%28.59%-28.36%63.09%-27.68%6.95%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 48.50%8.66%-9.63%
Return on Equity [ROE] (QoQ)ROE (QoQ) 233.00424.000.00M0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y) -0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M0.00M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -14.31%-8.77%-8.59%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -25.91%
Operating Income (QoQ)Op. Inc (QoQ) 71.68%10.50%1.83%-297.29%70.50%33.85%5.99%
Operating Income Growth (1y)Op. Inc Growth (1y) 1.16%-2.99%23.88%27.11%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 71.17%10.07%1.38%-296.78%69.60%33.89%6.05%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -1.46%-6.97%21.37%25.09%
Net Income (QoQ) 70.97%10.07%1.38%17.37%-45.96%33.89%6.05%
Net Income Growth (1y) 78.73%-6.97%21.37%25.09%
Net Cash Flow (QoQ)NCF (QoQ) -122.31%220.60%95.87%-92.00%-883.13%84.60%
Net Cash Flow Growth (1y)NCF Growth (1y) 142.03%-48.05%-118.91%
Income After Tax (QoQ) 73.94%10.08%1.35%-322.42%71.45%33.89%6.06%
Income After Tax Growth (1y) 2.36%-6.98%21.35%25.11%
Free Cash Flow (QoQ)FCF (QoQ) 14.13%20.61%7.44%-14.63%1.95%46.62%
Free Cash Flow Growth (1y)FCF Growth (1y) 27.67%17.41%44.46%
EPS (Diluted) (QoQ) -2.08%-296.78%69.60%47.43%8.00%
EPS (Diluted) Growth (1y) 35.28%41.68%
EPS (Basic) (QoQ) -2.08%-296.78%69.60%47.43%8.00%
EPS (Basic) Growth (1y) 35.28%41.68%
EBT (QoQ) 73.94%10.08%1.35%-322.42%71.45%33.89%6.06%
EBT Growth (1y) 2.36%-6.98%21.35%25.11%
EBIT (QoQ) 71.68%10.50%1.83%-297.29%70.50%33.85%5.99%
EBIT Growth (1y) 1.16%-2.99%23.88%27.11%
Cash from Operations (QoQ)Cash from Ops. (QoQ) 14.15%20.57%6.84%-13.88%1.97%46.58%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 27.65%17.39%44.44%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 145.19%183.72%-28.84%-52.40%-100.07%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) 135.62%-100.07%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 4.31%-32.38%-7.37%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 93.53%
Capital Expenditures (QoQ)Capex (QoQ) 11.43%-69.23%-1,541.67%109.83%47.06%
Capital Expenditures Growth (1y)Capex Growth (1y) -51.43%-35.90%
Assets (QoQ) -12.09%-36.97%-6.93%
Assets Growth (1y) -25.20%

First Tracks Biotherapeutics Growth Metrics API

Pull First Tracks Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TRAX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY